ストックスクリーナーアプリを入手
3.10
1.31%
0.04
アフターアワーズ：
3.25
0.15
+4.84%
Terns Pharmaceuticals Inc (TERN) 最新ニュース
Terns Pharmaceuticals to Participate in Upcoming June Investor C - GuruFocus
Terns Pharmaceuticals Secures Double Speaking Slots at Major Healthcare Conferences: What to Expect - Stock Titan
Terns Pharmaceuticals to Participate in Upcoming June Investor Conferences - GlobeNewswire
D. E. Shaw & Co. Inc. Increases Stock Holdings in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World
Millennium Management LLC Has $8.92 Million Stock Holdings in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World
Terns Pharmaceuticals’ SWOT analysis: promising pipeline drives stock potential By Investing.com - Investing.com Nigeria
Nuveen Asset Management LLC Buys 617,009 Shares of Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World
Terns Pharmaceuticals’ SWOT analysis: promising pipeline drives stock potential - Investing.com
Northern Trust Corp Has $3.28 Million Stake in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World
Deutsche Bank AG Has $2.21 Million Position in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World
BNP Paribas Financial Markets Acquires New Holdings in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World
Cubist Systematic Strategies LLC Decreases Position in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World
Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Shares Sold by The Manufacturers Life Insurance Company - Defense World
BMO Capital Markets Issues Pessimistic Forecast for Terns Pharmaceuticals (NASDAQ:TERN) Stock Price - Defense World
Terns Pharmaceuticals Selected for Oral Presentation at - GlobeNewswire
Terns Pharmaceuticals Selected for Oral Presentation at European - GuruFocus
Terns Pharmaceuticals Selected for Oral Presentation at European Hematology Association Congress For Preclinical Data on Novel Allosteric BCR-ABL Inhibitor TERN-701 - The Manila Times
Terns Pharmaceuticals Selected for Oral Presentation at European Hematology Association ... - Bluefield Daily Telegraph
Breakthrough: New Leukemia Drug TERN-701 Outperforms Standard Treatment in Multiple Resistance Cases - Stock Titan
Terns Pharma (TERN) Price Target Lowered by BMO Capital | TERN S - GuruFocus
Pfizer (PFE): Patent Developments Affect Terns Pharmaceuticals | PFE Stock News - GuruFocus
Pfizer (PFE): Patent Developments Affect Terns Pharmaceuticals | - GuruFocus
Terns Pharmaceuticals Reports Q1 2025 Financial Results - TipRanks
Dimensional Fund Advisors LP Raises Stake in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World
Hsbc Holdings PLC Grows Position in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World
Is Terns Pharmaceuticals, Inc. (TERN) the Low Risk High Reward Stock Set to Triple by 2030? - Insider Monkey
Terns Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Corporate Updates - GlobeNewswire
10 Low Risk High Reward Stocks Set to Triple by 2030 - Insider Monkey
Terns (TERN) Advances Clinical Programs with Promising Developme - GuruFocus
BRIEF-Terns Pharmaceuticals Q1 Net Income USD -23.908 Million - TradingView
Wells Fargo & Company MN Has $227,000 Stock Position in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World
MetLife Investment Management LLC Acquires 9,500 Shares of Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World
JPMorgan Chase & Co. Reduces Stake in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4) - The Manila Times
Terns Pharmaceuticals Reports Inducement Grants to New Employees - GuruFocus
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4) | TERN Stock News - GuruFocus
Biotech Firm Terns Awards Massive 325,000 Share Options Package to New Key Hires - Stock Titan
What is Terns Pharmaceuticals Inc (TERN) Stock Return on Shareholders’ Capital? - Sete News
Terns Pharmaceuticals Inc (TERN) deserves deeper analysis - uspostnews.com
Terns Pharmaceuticals to Participate in The Citizens Life Sciences Conference - The Manila Times
Terns Pharma Leaders to Reveal Latest Oncology and Obesity Drug Pipeline Updates at Major Conference - Stock Titan
An Analysis of Terns Pharmaceuticals Inc (TERN)’s Potential Price Growth - knoxdaily.com
Terns Pharmaceuticals Inc’s: Contrasting Stock Performances in a Volatile Market - investchronicle.com
Terns Pharmaceuticals Inc (NASDAQ: TERN) Stock Could Make A -543.09% Loss - Marketing Sentinel
Analyzing Ratios: Terns Pharmaceuticals Inc (TERN)’s Financial Story Unveiled - DWinneX
Market Resilience: Terns Pharmaceuticals Inc (TERN) Finishes Weak at 2.10, Down -9.87 - DWinneX
A Look at Terns Pharmaceuticals Inc (TERN) Shares in the Recent Past Indicates Growth - Sete News
TERN overperforms with a 2.86 increase in share price - uspostnews.com
Geode Capital Management LLC Has $8.40 Million Holdings in Terns Pharmaceuticals, Inc. (NASDAQ:TERN) - Defense World
A company insider recently sold 952 shares of Terns Pharmaceuticals Inc [TERN]. Should You also Consider to Sale? - knoxdaily.com
An Analysis Of Terns Pharmaceuticals Inc (TERN) Stock - Marketing Sentinel
We're Not Very Worried About Terns Pharmaceuticals' (NASDAQ:TERN) Cash Burn Rate - Yahoo Finance
TERN’s Stock Market Puzzle: Piecing Together 2023’s Performance - investchronicle.com
Terns Pharmaceuticals (NASDAQ:TERN) Receives Market Outperform Rating from JMP Securities - Defense World
0.95%
大文字化:
|
ボリューム (24 時間):